Literature DB >> 12186377

Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation.

Josie L Falany1, Nancy Macrina, Charles N Falany.   

Abstract

Estrogen stimulation is an important factor in human breast cancer cell growth and development. Metabolism of beta-estradiol (E2), the major endogenous human estrogen, is important in regulating both the level and activity of the hormone in breast tissues. Conjugation of E2 with a sulfonate moiety is an inactivation process since the sulfate ester formed by this reaction can not bind and activate the estrogen receptor. In human tissues including the breast, estrogen sulfotransferase (EST, SULT1E1) is responsible for high affinity E2 sulfation activity. EST is expressed in human mammary epithelial (HME) cells but not in most cultured breast cancer cell lines, including estrogen responsive MCF-7 cells. Stable expression of EST in MCF-7 cells at levels similar to those detected in HME cells significantly inhibits cell growth at physiologically relevant E2 concentrations. The mechanism of cell growth inhibition involves the abrogation of responses observed in growth factor expression in MCF-7 cells following E2 stimulation. MCF-7 cells expressing EST activity did not show a decrease in estrogen receptor-alpha levels, nor a characteristic increase in progesterone receptor or decrease in transforming growth factor-beta expression upon exposure to 100 pM or 1 nM E2. The lack of response in these MCF-7 cells is apparently due to the rapid sulfation and inactivation of free E2 by EST. These results suggest that loss of EST expression in the transformation of normal breast tissues to breast cancer may be an important factor in increasing the growth responsiveness of preneoplastic or tumor cells to estrogen stimulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186377     DOI: 10.1023/a:1016147004188

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

1.  Investigating the substrate binding mechanism of sulfotransferase 2A1 based on substrate tunnel analysis: a molecular dynamics simulation study.

Authors:  Li Zhao; Pupu Zhang; Shiyang Long; Linlin Wang; Hanyong Jin; Weiwei Han; Pu Tian
Journal:  J Mol Model       Date:  2016-07-08       Impact factor: 1.810

Review 2.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

3.  Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

4.  Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.

Authors:  Katie Jo Rohn; Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2012-05-16       Impact factor: 3.922

5.  Estrogen sulfotransferase inhibits adipocyte differentiation.

Authors:  Taira Wada; Chibueze A Ihunnah; Jie Gao; Xiaojuan Chai; Su Zeng; Brian J Philips; J Peter Rubin; Kacey G Marra; Wen Xie
Journal:  Mol Endocrinol       Date:  2011-08-04

Review 6.  Design and Interpretation of Human Sulfotransferase 1A1 Assays.

Authors:  Ting Wang; Ian Cook; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2015-12-09       Impact factor: 3.922

Review 7.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

8.  Testing the sulfotransferase molecular pore hypothesis.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

9.  The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.

Authors:  Paul A Foster; L W Lawrence Woo; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women.

Authors:  Shimrit Cohen; Yael Laitman; Bella Kaufman; Roni Milgrom; Uri Nir; Eitan Friedman
Journal:  Fam Cancer       Date:  2008-09-27       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.